Shares of Plexus Corp. (NASDAQ:PLXS – Get Rating) have earned an average rating of “Buy” from the eight ratings firms that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and four have given a buy recommendation to the company. The average 12-month target price among analysts that have updated their coverage on the stock in the last year is $98.12.
A number of equities analysts have recently issued reports on the company. Needham & Company LLC cut their price objective on Plexus from $95.00 to $90.00 and set a “buy” rating for the company in a report on Friday, January 28th. StockNews.com assumed coverage on Plexus in a report on Thursday, March 31st. They issued a “hold” rating for the company. Zacks Investment Research upgraded Plexus from a “strong sell” rating to a “hold” rating and set a $88.00 price objective for the company in a report on Wednesday, March 30th. Finally, TheStreet cut Plexus from a “b” rating to a “c+” rating in a report on Thursday, February 24th.
In other news, CAO Angelo Michael Ninivaggi, Jr. sold 1,200 shares of the stock in a transaction that occurred on Monday, May 2nd. The stock was sold at an average price of $80.66, for a total value of $96,792.00. Following the completion of the transaction, the chief accounting officer now owns 32,760 shares of the company’s stock, valued at approximately $2,642,421.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Steven J. Frisch sold 3,500 shares of the stock in a transaction that occurred on Tuesday, May 10th. The stock was sold at an average price of $82.13, for a total value of $287,455.00. Following the completion of the transaction, the insider now directly owns 56,666 shares of the company’s stock, valued at approximately $4,653,978.58. The disclosure for this sale can be found here. In the last quarter, insiders sold 8,801 shares of company stock valued at $721,475. Company insiders own 2.17% of the company’s stock.
NASDAQ PLXS traded up $1.09 during trading on Friday, reaching $82.17. The company’s stock had a trading volume of 86,398 shares, compared to its average volume of 114,973. The stock has a market capitalization of $2.28 billion, a PE ratio of 21.18 and a beta of 1.10. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.47 and a quick ratio of 0.64. The firm has a fifty day moving average of $81.48 and a 200 day moving average of $85.53. Plexus has a one year low of $72.88 and a one year high of $101.17.
Plexus (NASDAQ:PLXS – Get Rating) last announced its earnings results on Wednesday, April 27th. The technology company reported $0.95 earnings per share for the quarter, topping analysts’ consensus estimates of $0.83 by $0.12. Plexus had a return on equity of 11.05% and a net margin of 3.31%. The business had revenue of $888.70 million for the quarter, compared to analyst estimates of $839.76 million. During the same period in the prior year, the company earned $1.49 EPS. The company’s quarterly revenue was up .9% compared to the same quarter last year. Research analysts expect that Plexus will post 4.1 earnings per share for the current fiscal year.
About Plexus (Get Rating)
Plexus Corp., together with its subsidiaries, provides electronic manufacturing services in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. It offers design and development, supply chain, new product introduction, and manufacturing solutions, as well as aftermarket services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
- Get a free copy of the StockNews.com research report on Plexus (PLXS)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.